CDIO
CDIO
NASDAQ · Biotechnology

Cardio Diagnostics Holdings

$1.89
-0.06 (-2.88%)
As of Sep 28, 10:49 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,644.1% upside
Low Target $21.42
Average Target $33.03
High Target $37.66
Current Price $1.89
Current
$1.89
Target
$33.03
$21.42 $33.03 avg $37.66
Scenario Analysis
Bear Case
$21.42
1,031.1%
Low target
Base Case
$33.03
+1,644.1%
Avg target
Bull Case
$37.66
+1,888.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$7.91
-76.1% from high
52-Week Low
$0.97
+95.2% from low
Target vs 52W High
$33.03
+317.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%